A discrete cell cycle checkpoint in late G1 that is cytoskeleton-dependent and MAP kinase (Erk)-independent

Experimental Cell Research

Volumn 275, Issue 2, 2002, Pages 255-264

  Huang, Sui ^a   Ingber, Donald E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Cell cycle progression; Cell shape; Growth; Microfilament

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOCHALASIN D; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN P27;

ARTICLE; CAPILLARY ENDOTHELIUM; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

EID: 0036353562     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5504     Document Type: Article

References (69)

1. Role of cell shape in growth control
2. Fibronectin controls capillary endothelial cell growth by modulating cell shape
3. Cell-shape-dependent control of p27Kip and cell cycle progression in human capillary endothelial cells
4. The structural and mechanical complexity of cell-growth control
5. Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton
6. Forces on adhesive contacts affect cell function
7. Actin cytoskeleton organization in response to integrin-mediated adhesion
8. Integrin dynamics and matrix assembly: Tension-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis
9. Cell shape, cytoskeletal mechanics and cell cycle control in angiogenesis
10. Growth regulation by cell shape alteration and organization of the cytoskeleton
11. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1
12. Cell adhesion molecules, signal transduction and cell growth
13. Integrins and cell proliferation: Regulation of cyclin-dependent kinases via cytoplasmic signaling pathways
14. Fibronectin, integrins, and growth control
15. G1 phase progression: Cycling on cue
16. CDK inhibitors: Positive and negative regulators of G1-phase progression
17. The retinoblastoma protein and cell cycle control
18. G1 events and regulation of cell proliferation
19. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
20. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1
21. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27
22. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
23. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein
24. Integrating the MAP kinase signal into the G1 phase cell cycle machinery
25. Mammalian MAP kinase signalling cascades
26. Cell cycle-dependent activation of Ras
27. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblast
28. Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells
29. Multiple ras effector pathways contribute to G(1) cell cycle progression
30. Growth-factor-dependent mitogenesis requires two distinct phases of signalling
31. Integrin-mediated cell edhesion activates mitogen-activated protein kinases
32. Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2
33. Integrin-dependent activation of MAP kinase: A link to shape-dependent cell proliferation
34. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase
35. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein
36. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin
37. A synthetic inhibitor of the mitogen-activated protein kinase cascade
38. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome
39. Latrunculins - Novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D
40. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
41. Translational control of p27Kip1 accumulation during the cell cycle
42. A U-rich element in the 53 untranslated region is necessary for the translation of p27 mRNA
43. Efficient mammalian protein synthesis requires an intact F-actin system
44. Synthesis of proto-oncogene proteins and cyclins depends on intact micro-filaments
45. Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells
46. Lovastatin arrests CHO cells between the origin decision point and the restriction point
47. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
48. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1
49. Induction of cell proliferation in quiescent NIH3T3 cells by oncogenic c-Raf-1
50. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway
51. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells
52. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells
53. Rho GTPases and the actin cytoskeleton
54. Timing of cyclin D1 expression within G1 phase is controlled by Rho
55. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton
56. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity
57. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways
58. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle
59. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway
60. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
61. Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: Effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1
62. G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells
63. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling
64. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase
65. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex
66. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions
67. Involvement of the actin network in insulin signalling
68. Cooperative control of akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells
69. Geometric control of cell life and death